
MEI Pharma, Inc.
MEI Pharma, Inc.(MEIP)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · MEIP · 截至 2026年6月9日
活动摘要
买入笔数
6
P-Purchase only
卖出笔数
2
近12个月
买卖比
3.00
Buy/Sell (by trades)
整体情绪
MEI Pharma, Inc.内部人在过去近12个月净买入股份,可能反映对公司前景的信心。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
MEIP 季度内部人买卖趋势
MEIP 内幕交易卖出 · MEIP 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
MEIP 高管卖出股份 · MEIP 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 17, 2024 | Wood Steven D Director | Award | 3,100 | $10K | Form 4 |
| May 16, 2024 | Flynn James P Director | Award | 7,900 | $25K | Form 4 |
| Oct 20, 2023 | Funicular Funds, LP 10 percent owner | Other | 120,600 | $844K | Form 4 |
| Oct 20, 2023 | Anson Funds Management LP 10 percent owner | Other | 35,800 | $251K | Form 4 |
| Oct 20, 2023 | Anson Funds Management LP 10 percent owner | Other | 143,200 | $1.00M⚡ | Form 4 |
| Oct 11, 2023 | Funicular Funds, LP 10 percent owner | Other | 30,000 | $210K | Form 4 |
| Oct 11, 2023 | Anson Funds Management LP 10 percent owner | Other | 10,000 | $70K | Form 4 |
| Oct 11, 2023 | Anson Funds Management LP 10 percent owner | Other | 40,000 | $280K | Form 4 |
| Sep 22, 2023 | Anson Funds Management LP 10 percent owner | Purchase | 48,060 | $329K | Form 4 |
| Sep 22, 2023 | Funicular Funds, LP 10 percent owner | Purchase | 32,040 | $220K | Form 4 |
| Sep 21, 2023 | Anson Funds Management LP 10 percent owner | Purchase | 33,600 | $217K | Form 4 |
| Sep 20, 2023 | Anson Funds Management LP 10 percent owner | Purchase | 120,000 | $721K | Form 4 |
| Sep 21, 2023 | Funicular Funds, LP 10 percent owner | Purchase | 22,400 | $145K | Form 4 |
| Sep 20, 2023 | Funicular Funds, LP 10 percent owner | Purchase | 80,000 | $481K | Form 4 |
| Feb 28, 2023 | Baltic Charles V. III Director | Purchase | 81,500 | $18K | Form 4 |
| Jul 5, 2022 | GHALIE RICHARD G Chief Medical Officer | Other | 8,196 | $4K | Form 4 |
| Jul 2, 2021 | Urso David M Chief Operating Officer & GC | Other | 24,825 | $73K | Form 4 |
| Jul 2, 2021 | GOLD DANIEL P PHD CEO · Director | Other | 41,320 | $121K | Form 4 |
| May 25, 2021 | GOLD DANIEL P PHD CEO · Director | Option | 5,000 | $13K | Form 4 |
Anson Funds Management LP
10 percent owner
日期
Oct 20
股数
143,200
均价
$7.00
总金额
$1.00M ⚡
Anson Funds Management LP
10 percent owner
日期
Sep 22
股数
48,060
均价
$6.85
总金额
$329K
Anson Funds Management LP
10 percent owner
日期
Sep 21
股数
33,600
均价
$6.46
总金额
$217K
Anson Funds Management LP
10 percent owner
日期
Sep 20
股数
120,000
均价
$6.01
总金额
$721K
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 MEIP 内幕交易
MEIP 内幕交易
MEI Pharma, Inc.(MEIP)内幕交易数据来源于公司内部人(包括MEIP)提交的SEC Form 4申报文件。过去12个月内,0位内部人向SEC提交了交易申报。MEIP内部人近期主要在买入,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看MEI Pharma, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
MEIP 内幕交易 · 5个问题MEI Pharma, Inc.(MEIP)的内部人包括高管和董事,如MEIP等。过去12个月内,0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026